Dassault Systèmes SE (0HB4.L)
| Previous close | 39.10 |
| Open | 39.06 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 38.92 - 39.21 |
| 52-week range | 32.23 - 43.40 |
| Volume | |
| Avg. volume | 868,889 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
NEW YORK, July 26, 2024--Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced Eisai Inc. ("Eisai"), the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., as one of the first customers to harness its recently announced AI-driven Medidata Clinical Data Studio. Eisai Inc., will leverage this innovative data experience to gain unprecedented control over its clinical data, enable the execution of scalable and
- GlobeNewswire
Dassault Systèmes: Availability of the 2024 Half-year Financial Report
Press ReleaseVELIZY-VILLACOUBLAY, France — July 25, 2024 Availability of Dassault Systèmes’ 2024 Half-Year Financial Report (IFRS Half-Year Consolidated Condensed Financial Statements) Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced the availability to the public and the filing of its Half-Year Financial Report as of June 30, 2024 with the French Autorité des marchés financiers. The half-year condensed consolidated financial statements included in this report are establi
- Business Wire
ASICS and Dassault Systèmes Demonstrate On-Demand, Personalized Footwear
VELIZY-VILLACOUBLAY, France, July 25, 2024--Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and ASICS have jointly opened a studio in Paris to test a new service providing on-demand sockliners personalized for individual foot shape.
